Loop Diuretics: Mechanism, Potassium Loss and Metabolic Alkalosis
If you’ve learned the electrolyte effects of loop diuretics as a list, try following the sodium instead. Loop diuretics block NKCC2, the sodium-potassium-2 chloride cotransporter in the thick ascending limb of the loop of Henle. That transporter normally moves salt out of the kidney tubule so it can return to the blood. Block it, and more salt and water leave in the urine.
Sachi, CRNA
CRNA

In This Article (8 sections)
The rest of the nephron helps explain what happens to potassium and bicarbonate. Start with the diuretic lessons in the CRNA Club learning library through the seven-day platform trial, then follow the sodium downstream before memorizing the electrolyte effects.
Why block sodium reabsorption here?
Reabsorption means moving a filtered substance out of the tubule and back toward the blood. The thick ascending limb normally reabsorbs a substantial amount of sodium chloride. Water doesn’t readily follow across this particular segment.
That separation helps build the salt concentration deeper in the kidney, which other segments use to conserve water. Blocking NKCC2 changes that concentrating system and leaves more sodium traveling onward through the tubule.
When enough drug reaches the site and the kidney responds, urinary salt and water loss increase. Furosemide is a familiar example. It can relieve congestion, but more urine doesn’t by itself prove the kidney has recovered or cardiac output has improved.
Why can potassium fall after a loop diuretic?
Follow the extra sodium into the distal nephron, farther along the tubule. As sodium is taken back up there, the electrical conditions favor potassium moving into the urine.
Volume loss adds another effect. The renin-angiotensin-aldosterone system responds by trying to retain sodium. Aldosterone also promotes potassium secretion, so potassium loss can increase.
That is why “it dumps potassium” leaves out much of the explanation. The drug blocks a transporter in the loop, and part of the potassium effect happens farther downstream.
The furosemide prescribing information describes hypokalemia, hypomagnesemia and hypochloremic alkalosis among its electrolyte effects. Review that sequence in the diuretic lessons. Then explain why you would check magnesium when potassium remains difficult to correct.
Why are calcium and magnesium affected too?
Normal transport in the thick ascending limb helps make the fluid inside the tubule electrically positive. That favors calcium and magnesium moving out between neighboring cells and being reabsorbed.
Loop inhibition disrupts that electrical effect. More calcium and magnesium can stay in the tubular fluid and leave in the urine. You changed sodium transport, but the consequences reach other electrolytes too.
Why does bicarbonate rise?
Several effects contribute to metabolic alkalosis. Chloride and potassium can become depleted. The distal nephron secretes hydrogen ions, which removes acid, while volume depletion changes how the kidney handles bicarbonate.
Losing acid and retaining bicarbonate make the blood more alkaline. “Contraction alkalosis” is a useful name, but shrinking the fluid volume isn’t the whole explanation. Chloride, potassium and continued renal handling help sustain the problem.
| Change you notice | What to check behind it |
|---|---|
| Potassium falling | Distal sodium delivery, potassium loss and aldosterone effects |
| Magnesium falling | Reduced reabsorption and urinary loss |
| Bicarbonate rising | Chloride and potassium depletion, hydrogen secretion and bicarbonate handling |
| Hypotension or rising nitrogenous waste levels | Circulating volume, perfusion and the overall response |
Not every patient develops every change. Follow the results the patient actually has.
What would you check after a day of diuresis?
In this fictional case, a congested patient’s urine output increases. Potassium falls from 4.1 to 3.2 mmol/L, and bicarbonate rises from 25 to 32 mmol/L.
The trend fits possible diuretic effects. Now check what else might be contributing. Review chloride, magnesium and kidney function. Look at intake and other losses. Vomiting or gastric drainage, for example, gives you another reason for alkalosis.
And how is the patient doing? Compare urine output with intake, weight, symptoms and the examination. Check blood pressure and perfusion. A large urine volume doesn’t tell you all of that.
What if there is very little diuresis?
The drug has to reach the tubule and the kidney has to respond. Kidney function, previous exposure, sodium intake and the degree of congestion all affect the result.
A poor response needs another assessment. It doesn’t prove irreversible kidney failure, and it doesn’t tell you to double the dose in every patient. Dose changes or combination therapy need the clinical plan and monitoring.
Our Final Thoughts
Sketch the nephron from NKCC2 and follow the sodium past the blocked transporter. Then explain the falling potassium and rising bicarbonate in the case. Take the step that’s still unclear back to your notes. You can build the explanation a little at a time.
Keep working through the laboratory changes
Use the diuretic and electrolyte teaching in the seven-day CRNA Club platform trial to continue. Try explaining the case’s laboratory trend, including another cause you would check.


